Biosimilars are reshaping the Canadian pharmaceutical landscape, raising important regulatory, patent and trademark considerations for both biologics and biosimilar industries. This webinar will provide a practical overview of the Canadian framework governing biosimilar products including:
- Health Canada’s approval pathway
- Provincial and territorial substitution policies
- Role of the Patented Medicine Prices Review Board (PMPRB)
- Key trademark and branding considerations
- Availability, if any, of patent listing and Certificates of Supplementary Protection